Literature DB >> 17409496

Interaction of Mat-8 (FXYD-3) with Na+/K+-ATPase in colorectal cancer cells.

Junko Arimochi1, Ayako Ohashi-Kobayashi, Masatomo Maeda.   

Abstract

Mat-8 was fused with a Myc-tag or green fluorescent protein at its carboxyl terminus, and then expressed in Chinese hamster ovary K1 cells. Determination of the cellular localization of the tagged proteins suggested that they were localized on the intracellular membrane, being not only detected around the nuclear envelope but also partly overlapping with markers for endosomes and Golgi bodies. However, Mat-8 with the Myc-tag was detected on the plasma membrane as well as the intracellular membrane, when it was expressed in colorectal cancer cells. The membrane fraction of the cancer cells was solubilized and immuno-precipitated with an antibody for the Myc-tag. Western-blotting analysis demonstrated that the Na+/K+-ATPase alpha subunit was present in the precipitate. Furthermore, the immuno-precipitate obtained with an antibody for the Na+/K+-ATPase alpha subunit reacted with that for the Myc-tag. These results suggested that Mat-8 could be associated with Na+/K+-ATPase similar to other FXYD family members. The Gly41-->Arg mutation in the transmembrane region of Mat-8 inhibited its association with the Na+/K+-ATPase alpha subunit and localization on the plasma membrane, whereas the Cys44-->Ala or Cys49-->Ala substitution did not. Thus the conserved Gly41 residue in the transmembrane domain could be indispensable for localization of Mat-8 on the cell surface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409496     DOI: 10.1248/bpb.30.648

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.

Authors:  Stéphanie Bibert; Chia-Chi Liu; Gemma A Figtree; Alvaro Garcia; Elisha J Hamilton; Francesca M Marassi; Kathleen J Sweadner; Flemming Cornelius; Käthi Geering; Helge H Rasmussen
Journal:  J Biol Chem       Date:  2011-03-30       Impact factor: 5.157

2.  Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis.

Authors:  Koji Okudela; Takuya Yazawa; Jun Ishii; Tetsukan Woo; Hideaki Mitsui; Tomoyasu Bunai; Masashi Sakaeda; Hiroaki Shimoyamada; Hanako Sato; Michihiko Tajiri; Nobuo Ogawa; Munetaka Masuda; Haruhiko Sugimura; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

3.  S163 is critical for FXYD5 modulation of wound healing in airway epithelial cells.

Authors:  Timothy J Miller; Pamela B Davis
Journal:  Wound Repair Regen       Date:  2008 Nov-Dec       Impact factor: 3.617

4.  Na⁺/K⁺-ATPase E960 and phospholemman F28 are critical for their functional interaction.

Authors:  Mounir Khafaga; Julie Bossuyt; Luiza Mamikonian; Joseph C Li; Linda L Lee; Vladimir Yarov-Yarovoy; Sanda Despa; Donald M Bers
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

Review 5.  Beneficial Renal and Pancreatic Phenotypes in a Mouse Deficient in FXYD2 Regulatory Subunit of Na,K-ATPase.

Authors:  Elena Arystarkhova
Journal:  Front Physiol       Date:  2016-03-07       Impact factor: 4.566

Review 6.  The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease.

Authors:  Michael V Clausen; Florian Hilbers; Hanne Poulsen
Journal:  Front Physiol       Date:  2017-06-06       Impact factor: 4.566

7.  FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment.

Authors:  Satoru Yonekura; Kosuke Ueda
Journal:  Cancers (Basel)       Date:  2022-07-23       Impact factor: 6.575

8.  Overexpression of FXYD-3 is involved in the tumorigenesis and development of esophageal squamous cell carcinoma.

Authors:  Zhen-Long Zhu; Bao-Yong Yan; Yu Zhang; Yan-Hong Yang; Ming-Wei Wang; Hanswalter Zentgraf; Xiang-Hong Zhang; Xiao-Feng Sun
Journal:  Dis Markers       Date:  2013-08-27       Impact factor: 3.434

9.  AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.

Authors:  S Gnosa; H Zhang; V P Brodin; J Carstensen; G Adell; X-F Sun
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.